2TSUKASAKI N, WHITWORTH CA, RYBAK LP. Acute changes in cochlear potentials due to cisplatin [J]. Hear Res, 2000,149 (1-2):189.
3MEECH RP, CAMPBELL KC, HUGHES LP, et al. A semiquantitalive analysis of the effects of cisplatin on the rat stria vascularis[J]. Hear Res,1998, 124(1-2):44.
4MA KISEL, LN KULIK, IS TSYBOVSKY, et al. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat [J].2001,1(216): 105-114.
5T NOMURA, K YASUDA, T YAMADA, et al.Gene expression and anfitumor effects following direct interferon (IFN)-g gene transfer with naked plasmid DNA and I)C-chol liposome complexes in mice[J]. Gene Therapy, 1999, 6:121-129.
6GEORGIA KOROMILA, GEORGE PA, MICHANETZIS, et al. Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: Effect on haemecompatibility[J]. Biomaterials, 2006,27(12) :2525-2533.
7GEORGOULIAS V, ARDAVANIS A , AGELIDOU A, et al. Docetaxel Versus Docetaxel Plus Cisplatin as Front2line Treatment of Patients with Advanced Non-small Lung Cancer: a Randomized, Muhicenter Phase Ⅲ Trial[J]. J Clin Oncol, 2004, 22(13):2602-2609.
8KIM YH, KIM JS, CHOI YH, et al. Phase Ⅱ Study of Docetaxel and Cisplatin Combination Chemotherapy in Metastatic or Unresectable Localized Non Small Cell Lung Cancer[J]. Int J Clin Oncot, 2002,7(2) :114-119.
